We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Efficiency Study of Low Dose of IL-2 to Prevent Relapse in Standard Risk Leukemia After Transplantation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01517347
Recruitment Status : Terminated (Because the conditional power was 0.083, the Data and Safety Monitoring Board recommended halting the study due to futility after the 1st interim analysis.)
First Posted : January 25, 2012
Last Update Posted : October 24, 2016
Information provided by (Responsible Party):
Xiaojun Huang, Peking University People's Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : August 2015
  Study Completion Date : August 2015